Tinnitus: Current understanding and contemporary management

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 18, Issue 5, 2010, Pages 363-368

  Seidman, Michael D ^a   Standring, Robert T ^a   Dornhoffer, John L ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

clinical evaluation; etiology; otology; tinnitus; treatment

Indexed keywords

ALPRAZOLAM; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMITRIPTYLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; GINKGO BILOBA EXTRACT; LIDOCAINE; LOOP DIURETIC AGENT; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; SALICYLIC ACID DERIVATIVE; SERTRALINE; STEROID; VITAMIN B COMPLEX;

ACOUSTIC IMPEDANCE; ACOUSTIC NEURINOMA; ACUPUNCTURE; ALZHEIMER DISEASE; ANEMIA; ANXIETY; AUDITORY MASKING; CELL DAMAGE; CERUMEN IMPACTION; CLINICAL EVALUATION; CLINICAL TRIAL; COCHLEA INJURY; COCHLEA PROSTHESIS; CYANOCOBALAMIN DEFICIENCY; DEPRESSION; DIETARY INTAKE; DRUG TREATMENT FAILURE; ELECTROSTIMULATION; FIBROMYALGIA; HEAD INJURY; HEARING LOSS; HEARING TEST; HUMAN; HYPERLIPIDEMIA; HYPERTHYROIDISM; HYPOTHYROIDISM; IATROGENIC DISEASE; LIFESTYLE MODIFICATION; MAGNETOENCEPHALOGRAPHY; MEDICAL HISTORY; MENIERE DISEASE; MENINGITIS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OTITIS; OTITIS MEDIA; OTOSCLEROSIS; PATIENT COUNSELING; PERCEPTION DEAFNESS; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRESBYACUSIS; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPEECH AUDIOMETRY; SYPHILIS; TEMPOROMANDIBULAR JOINT DISORDER; THYROID DISEASE; TINNITUS; TRANSCRANIAL MAGNETIC STIMULATION; TYMPANOMETRY; ZINC DEFICIENCY;

HUMANS; TINNITUS;

EID: 77957793987     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32833c718d     Document Type: Review

References (72)

1. Stouffer J, Tyler R. Characterization of tinnitus by tinnitus patients. J Speech Hear Disord 1990; 55:439-453.
2. Seidman M, Arenberg J, Shirwany N. Palatal myoclonus as a cause of objective tinnitus: a report of six cases and a review of the literature. Ear Nose Throat J 1999; 78:292-294;296-297.
3. Seidman M, Jacobson G. Update on tinnitus. Otolaryngol Clin North Am 1996; 29:455-465.
4. Seidman MD, Babu S. Alternative medications and other treatments for tinnitus: facts from fiction [Review] [41 refs]. Otolaryngol Clin North Am 2003; 36:359-381.
5. Adams P, Hendershot G, Marano M. Current estimates from the National Health Interview Survey, 1996. Vital and health statisticsSeries 10, Datafrom the National Health Survey 1999; 200:1.
6. Johansson M, Arlinger S. Prevalence of hearing impairment in a population in Sweden: prevalencia de las pérdidas auditivas en una población de Suecia. Int J Audiol 2003; 42:18-28.
7. Kvestad E, Czajkowski N, Engdahl B, et al. Low heritability oftinnitus: results from the second nord-trondelag health study. Arch Otolaryngol Head Neck Surg 2010; 136:178-182.
8. Schleuning AJ 2nd. Management of the patient with tinnitus [Review] [13 refs]. Med Clin North Am 1991; 75:1225-1237.
9. Eggermont J. Pathophysiologyoftinnitus. Prog Brain Res 2007; 166:19-35.
10. Crummer RW, Hassan GA. Diagnostic approach to tinnitus [Review] [21 refs]. Am Fam Physician 2004; 69:120-126.
11. Fortune DS, Haynes DS, Hall JW 3rd. Tinnitus. Current evaluation and management. Med Clin North Am 1999; 83:153-162.
12. Lockwood A, Salvi R, Burkard R. Tinnitus. N Engl J Med 2002;347:904-910.
13. Wiegand D, Fickel V. Acoustic neuroma-the patient's perspective: subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients. Laryngoscope 2009; 99:179-187.
14. Guitton M, Caston J, Ruel J, et al. Salicylate inducestinnitusthrough activation of cochlear NMDA receptors. J Neurosci 2003; 23:3944-3952.
15. Folmer R, Griest S, Meikle M, Martin W. Tinnitus severity, loudness, and depression. Otolaryngol Head Neck Surg 1999; 121:48-51.
16. Deniz M, Bayazit YA, Celenk F, et al. Significance of serotonin transporter gene polymorphism in tinnitus. Otol Neurotol 2010; 31:19-24.
17. Chung DY, Gannon RP, Mason K. Factorsaffecting the prevalence oftinnitus. Audiology 1984; 23:441-452.
18. Zenner H, Ernst A. Cochlear-motor, transduction and signal- transfertinnitus: models for three types of cochlear tinnitus. Eur Arch Otorhinolaryngol 1993; 249:447-454.
19. Eggermont J. On the pathophysiology of tinnitus; a review and a peripheral model. Hear Res 1990; 48 (1-2):111-123.
20. Konig O, Schaette R, Kempter R, Gross M. Course of hearing loss and occurrence of tinnitus. Hear Res 2006; 221 (1-2):59-64.
21. Barnea G, Attias J, Gold S, Shahar A. Tinnitus with normal hearing sensitivity: extended high-frequency audiometry and auditory-nerve brain-stem-evoked responses. Int J Audiol 1990; 29:36-45.
22. Henry J, Meikle M, Gilbert A, editors. Audiometric correlates of tinnitus pitch: insights from the Tinnitus Data Registry. 1999.
23. Ochi K, Ohashi T, Kenmochi M. Hearing impairment and tinnitus pitch in patients with unilateral tinnitus: comparison of sudden hearing loss and chronictinnitus. Laryngoscope 2009; 113:427-431.
24. Hendrickx J, Huyghe J, Demeester K, et al. Familial aggregation of tinnitus: a European multicentre study. B-ENT 2007; 3:51-60.
25. Petersen H, Andersen T, Frederiksen H, et al., editors. The heritability of tinnitus: a twin study. Aarhus, Denmark, Nordic Epidemiology Congress; 2002.
26. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 1996; 122:143-148
27. Coherence analysis of brain activity associated with Tinnitus [database on the Internet] 2008. www. megimaging. com/tinnitusBiomag 2008. pd.
28. Dobie R. Clinical trials and drug therapy for tinnitus. In: Snow JB, editor. Tinnitus: Theory and management. Hamilton: BC Decker; 2004. pp. 266-277.
29. Langguth B, Salvi R, Elgoyhen A. Emerging pharmacotherapy of tinnitus. Expert Opin Emerging Drugs 2009; 14:687-702.
30. Vio M, Holme R. Hearing loss and tinnitus: 250 million people and a US $10 billion potential market. Drug Discovery Today 2005; 10:1263-1265.
31. Tyler RS. Tinnitus handbook. San Diego: Singular Publishing Group; 2000. pp. 378-396.
32. Feldmann H. History of tinnitus research. In: Shulman A, editor. Tinnitus: diagnosis/treatment. San Diego:Singular Publishing Group; 1997. pp. 3-37.
33. Zhang JS, Zhang XG, Beydoun H, et al. Cortical electrical suppression of tinnitus and modulation of its related neural activity. N Z Med J 2010; 123: 77-167.
34. Rubinstein J, Tyler R, Johnson A, Brown C. Electrical suppression of tinnitus with high-rate pulse trains. Otol Neurotol 2003; 24:478-485.
35. Seidman MDMDF, Ridder DDMD, Elisevich KMDP, et al. Direct electrical stimulation of Heschl's Gyrus for tinnitus treatment [Miscellaneous Article]. Laryngoscope 2008; 118:491-500.
36. Kay N. Oral chemotherapy in tinnitus. Br J Audiol 1981; 15:123-124.
37. Johnson R, Brummett R, Schleuning A. Use of alprazolam for reliefoftinnitus: a double-blind study. Arch Otolaryngol Head Neck Surg 1993; 119:842-845.
38. Gananca M, Caovilla H, Gananca F, et al. Clonazepam in the pharmacological treatment of vertigo and tinnitus. Int Tinnitus J 2002; 8:50.
39. Bayar N, Böke B, Turan E, Belgin E. Efficacyofamitriptyline in thetreatment of subjective tinnitus. J Otolaryngol 2001; 30:300.
40. Robinson S, Viirre E, Bailey K, et al. Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects. Psychosom Med 2005; 67:981.
41. Zoger S, Svedlund J, Holgers K. The effects of sertraline on severe tinnitus suffering-a randomized, double-blind, placebo-controlled study. J Clin Psy-chopharmacol 2006; 26:32.
42. Robinson S. Antidepressants for treatment of tinnitus. Prog Brain Res 2007; 166:263-271.
43. Donaldson I. Tegretol: a double blind trial in tinnitus. J Laryngol Otol 1981; 95:947-951.
44. Hulshof J, Vermeij P. The value of carbamazepine in the treatment oftinnitus. ORL; Journal for oto-rhino-laryngology and its related specialties 1985; 47:262-266.
45. Shulman A. Gabapentin and tinnitus relief. Int Tinnitus J 2008; 14:1-5.
46. Bauer C, Brozoski T. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 2009; 116:675-681.
47. Figueiredo R, Langguth B, Mello de Oliveira P, Aparecida de Azevedo A. Tinnitus treatment with memantine. Otolaryngol Head Neck Surg 2008; 138:492-496.
48. Holstein N. Ginkgoextracthelps patients suffering from tinnitus. Reviewof the literature shows: tinnitus decreases [German]. MMW Fortschritte der Medizin 2000; 142:46.
49. Ernst E, Stevinson C. Ginkgo biloba for tinnitus: a review [Review] [25 refs]. Clin Otolaryngol Allied Sci 1999; 24:164-167.
50. Hilton M, Stuart E. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev 2004; 2:2CD003852.
51. Rejali D, Sivakumar A, Balaji N. Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clin Otolaryngol Allied Sci 2004; 29:226-231.
52. Meyer B. Tinnitus-multicenter study: a multicentric study of the ear. Ann Otolaryngol 1980; 103:185-188.
53. Shemesh Z, Attias J, Ornan M, et al. Vitamin B12 deficiency in patients with chronic-tinnitus and noise-induced hearing loss. Am J Otolaryngol 1993; 14:94-99.
54. Shulman A. Subjective idiopathictinnitus: a unified plan of management. Am J Otolaryngol 1993; 13:63-75.
55. Jastreboff P, Jastreboff M. Tinnitus retraining therapy (TRT) as a method for treatment of tinnitus and hyperacusis patients. J Am Acad Audiol 2000; 11:162-177.
56. Schechter M, Henry J. Assessment and treatment of tinnitus patients using a 'Masking Approach'. J Am Acad Audiol 2002; 13:545-558. (Pubitemid 36204246)
57. Henry J, Schechter M, Zaugg T, et al. Clinical trial to compare tinnitus masking and tinnitus retraining therapy. Acta Otolaryngol 2006; 126:64-69.
58. Davis PB, Paki B, Hanley PJ. Neuromonics tinnitus treatment: third clinical trial. Ear Hear 2007; 28:242-259.
59. Dornhoffer J, Mennemeier M. Transcranial magnetic stimulation and tinnitus: implications for theory and practice. J Neurol Neurosurg Psychiatry 2007; 78:113.
60. Kleinjung T, Eichhammer P, Langguth B, et al. Long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic tinnitus. Otolaryngol Head Neck Surg 2005; 132:566-569.
61. Plewnia C, Reimold M, Najib A, et al. Moderatetherapeuticefficacyof positron emission tomography-navigated repetitive transcranial magnetic stimulation for chronic tinnitus: a randomised, controlled pilot study. J Neurol Neurosurg Psychiatry 2007; 78:152-156.
62. Richter G, Mennemeier M, Bartel T, et al. Repetitive transcranial magnetic stimulation fortinnitus: a case study. Laryngoscope 2009; 116:1867-1872. (Pubitemid 44511378)
63. Rossi S, De Capua A, Ulivelli M, et al. Effectsofrepetitivetranscranial magnetic stimulation on chronictinnitus: a randomised, crossover, double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 2007; 78:857-863.
64. Smith J, Mennemeier M, Bartel T, et al. Repetitive transcranial magnetic stimulation for tinnitus: a pilot study. Laryngoscope 2007; 117:529-534.
65. Bohning D. Introduction and overview of TMS physics. In: George M, Belmaker R, editors. Transcranial magnetic stimulation in neuropsychiatry. Washington, DC: American Psychiatric Association; 2000. pp. 13-44.
66. Cohen L, Roth B, Nilsson J, et al. Effects of coil design on delivery of focal magnetic stimulation. Technical considerations. Electroencephalogr Clin Neurophysiol 1990; 75:350-357.
67. Roth B, Momen S, Turner R. Algorithm for the design of magnetic stimulation coils. Med Biol Eng Comput 1994; 32:214-216.
68. Chen R, Classen J, Gerloff C, et al. Depression of motor cortex excitability by low-frequency transcranial magneticstimulation. Neurology 1997; 48:1398-1403.
69. Pascual-Leone A, Tormos J, Keenan J, et al. Study and modulation of human cortical excitabilitywith transcranial magnetic stimulation. J Clin Neurophysiol 1998; 15:333-343.
70. Wu T, Sommer M, Tergau F, Paulus W. Lasting influence of repetitive transcranial magnetic stimulation on intracortical excitability in human sub-jects. Neurosci Lett 2000; 287:37-40.
71. Fox P, Ingham R, George M, et al. Imaging human intra-cerebral connectivity by PET during TMS. Neuroreport 1997; 8:2787-2791.
72. Kimbrell T, Little J, Dunn R, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999; 46:1603-1613.